Renovia, a company that develops therapeutic devices and diagnostic tools for women with pelvic disorders, has recently secured $42.3 million in financing. This funding will aid the company in clinical trials, product and corporate development, and future commercial launches.
The group that provided this funding is led by Perceptive Advisors and Ascension Ventures. Marc Beer, Co-Founder, Chairman and Chief Executive Officer of Renovia expressed his excitement for this funding and what the company can accomplish as a result. The company plans to work on four new products as a result of this funding.
Renovia recently expanded their leadership team. In 2018 they appointed Jessica McKinney, PT, MS as Vice President of Medical Affairs and Clinical AdvocacySamantha Pulliam, MD as its Chief Medical Officer, and Jim O’Connor as General Counsel.
Renovia believes that they will be able to provide valuable data for patients that may aid to decrease long-term healthcare costs. This can shed light on new, and innovative, treatment options that can drastically improve quality of life.
Renovia’s goal is to address a growing, global, problem. Urinary incontinence affects over 250 million people worldwide. Their current, FDA- cleared device, works to treat weakened pelvic muscles in real time. This provides valuable therapy to the patient as well as data and new insight into their specific case. This funding may advance this process as well as lead to new ones.
Mark Beer is a co-founder of Renovia and he also serves as its current Chairman and CEO. He was educated at Miami (OH) University, where he received a B.S. Mr. Beer has 25 years of development and commercialization experience in the pharmaceutical, diagnostic, and Biotech industries. He has ushered in a period of growth in most of the companies in which he has had leadership roles.
Mark Beer’s resume shows an eclectic and strong body of experience in the healthcare industry. He has held a variety of sales and marketing positions during his two and a half decades of professional experience. He has also served on numerous boards for many companies. These companies include, Good Start Genetics Inc., and Minerva Neurosciences Inc. Learn more: https://www.businesswire.com/news/home/20180821005199/en/Renovia-Completes-42.3-Million-Series-Financing